Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ibritumomab Tiuxetan

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
    CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference

    02 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference-301068743.html

    PRNEWSWIRE
    02 Jun 2020
    Share Share
    CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China
    CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China

    12 Aug 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-launch-of-evomela-melphalan-for-injection-in-china-300899773.html

    PR NEWSWIRE
    12 Aug 2019
    Share Share
    CASI Pharma Announces China National Medical Products Administration (NMPA)
    CASI Pharma Announces China National Medical Products Administration (NMPA)

    19 Feb 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-china-national-medical-products-administration-nmpa-approval-of-cta-to-conduct-confirmatory-clinical-trial-for-zevalin-300797617.html

    PR NEWSWIRE
    19 Feb 2019
    Share Share
    Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
    Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

    25 Jan 2019

    // PHARMA TECH

    https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/

    PHARMA TECH
    25 Jan 2019
    Share Share
    Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M
    Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

    18 Jan 2019

    // Alaric Dearment MEDCITY NEWS

    https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1

    Alaric Dearment MEDCITY NEWS
    18 Jan 2019
    Share Share
    Spectrum Pharms' Biological Ibritumomab Tiuxetan Receives Supplemental Approval in US
    Spectrum Pharms' Biological Ibritumomab Tiuxetan Receives Supplemental Approval in US

    12 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019

    FDA
    12 Dec 2018
    Share Share